<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Terry KL</submitter><funding>NCI NIH HHS</funding><pagination>272-7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3076782</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>1(4)</volume><pubmed_abstract>Recent epidemiologic evidence supports a role for MUC1 in ovarian carcinogenesis; therefore, we hypothesized that common genetic variation in the genes responsible for glycosylation of MUC1 may influence ovarian cancer risk. In a genome-wide association study of ovarian cancer, we observed an association between a non-synonymous SNP (rs2271077) in the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosainyltransferase 2 (GALNT2) gene and ovarian cancer risk (p=0.005). We sought to validate the association in four population based ovarian cancer case-control studies collaborating through the Ovarian Cancer Association Consortium. Although rs2271077 was associated with a significantly increased risk (Odds Ratio (OR) = 1.37, 95% Confidence Interval (CI) = 1.06-1.77) in one study </pubmed_abstract><journal>International journal of molecular epidemiology and genetics</journal><pubmed_title>A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies.</pubmed_title><pmcid>PMC3076782</pmcid><funding_grant_id>N01 CN025403</funding_grant_id><funding_grant_id>R01 CA058598</funding_grant_id><funding_grant_id>R01 CA054419</funding_grant_id><pubmed_authors>Cramer DW</pubmed_authors><pubmed_authors>Terry KL</pubmed_authors><pubmed_authors>Titus-Ernstoff L</pubmed_authors><pubmed_authors>Gayther SA</pubmed_authors><pubmed_authors>Pharaoh PD</pubmed_authors><pubmed_authors>Song H</pubmed_authors><pubmed_authors>Goodman MT</pubmed_authors><pubmed_authors>Vitonis AF</pubmed_authors><pubmed_authors>Wilkens LR</pubmed_authors><pubmed_authors>Menon U</pubmed_authors><pubmed_authors>Lurie G</pubmed_authors><pubmed_authors>Carney ME</pubmed_authors><pubmed_authors>Ramus SJ</pubmed_authors><pubmed_authors>Gentry-Maharaj A</pubmed_authors><pubmed_authors>Birrer MJ</pubmed_authors><pubmed_authors>Hernandez D</pubmed_authors></additional><is_claimable>false</is_claimable><name>A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies.</name><description>Recent epidemiologic evidence supports a role for MUC1 in ovarian carcinogenesis; therefore, we hypothesized that common genetic variation in the genes responsible for glycosylation of MUC1 may influence ovarian cancer risk. In a genome-wide association study of ovarian cancer, we observed an association between a non-synonymous SNP (rs2271077) in the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosainyltransferase 2 (GALNT2) gene and ovarian cancer risk (p=0.005). We sought to validate the association in four population based ovarian cancer case-control studies collaborating through the Ovarian Cancer Association Consortium. Although rs2271077 was associated with a significantly increased risk (Odds Ratio (OR) = 1.37, 95% Confidence Interval (CI) = 1.06-1.77) in one study </description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Jul</publication><modification>2025-04-21T19:13:30.97Z</modification><creation>2019-03-27T00:40:40Z</creation></dates><accession>S-EPMC3076782</accession><cross_references><pubmed>21532840</pubmed></cross_references></HashMap>